You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
Keep heart failure patients alive2, active3 and away4 from the hospital, using advanced medical technology.
ICD therapy: Efficacy in modern heart failure patients while limiting side effects - M. Meine (Utrecht, NL) - (11:07)
(11:07 minutes)
More information (see more)
Less information (see less)
Maximising the clinical benefit from left ventricular assist devices - L. Tops (Leiden, NL) - (13:07)
(13:08 minutes)
More information (see more)
Less information (see less)
Maximising Outcomes with Device Therapy for Heart Failure: Introduction - M. Cowie (London, GB) - (01:48)
(1:48 minutes)
More information (see more)
Less information (see less)
Cardiac resynchronisation therapy: Current status and latest documents - K. Witte (Leeds, GB) - (13:29)
(13:30 minutes)
More information (see more)
Less information (see less)
Implementing Remote Device Therapies in the Modern Heart Failure Clinic - W. Mullens (Genk, BE) - (20:41)
(20:41 minutes)
More information (see more)
Less information (see less)
Remote Patient Management For The Post-Covid-19 Era: Practical Experience from Greater Manchester - F.Z. Ahmed (Manchester, GB) - (08:14)
(8:14 minutes)
More information (see more)
Less information (see less)
Remote Management of Device HF Patients Using Risk Assessment Algorithms - H. Burri (Geneva, CH) - (13:22)
(13:22 minutes)
More information (see more)
Less information (see less)
Indications and Adoption of CRT: Who is doing what to whom? - K. Dickstein (Stavanger, NO) - (18:27)
(18:27 minutes)
More information (see more)
Less information (see less)
Maximising the Clinical Benefit from Left Ventricular Assist Devices - L. Tops (Leiden, NL) - (14:33)
(14:33 minutes)
More information (see more)
Less information (see less)
Controversies and Myths in CRT - K. Witte (Leeds, GB) - (19:04)
(19:04 minutes)
More information (see more)
Less information (see less)
Which Patient Outcomes are Most Meaningful In Heart Failure? - M. Cowie (London, GB) - (17:20)
(17:20 minutes)
More information (see more)
Less information (see less)
Left ventricular assist devices: which patients and what are the results-Dr. Bushnaq - (14:55)
(14:55 minutes)
More information (see more)
Less information (see less)
Introduction-An update on device technologies in heart failure-Professor Seferovic - (08:32)
(8:32 minutes)
More information (see more)
Less information (see less)
Summary and Conclusions: An update on device technologies in heart failure-Professor Mullens - (02:39)
(2:39 minutes)
More information (see more)
Less information (see less)
Cardiac Resynchronization Therapy (CRT) Which patients and what are the results-Professor Linde - (14:09)
(14:09 minutes)
More information (see more)
Less information (see less)
Disparity in care for Device Therapy in Europe-Professor Dickstein. - (14:50)
(14:50 minutes)
More information (see more)
Less information (see less)
See the HeartWare™ HVAD™ system Instructions for Use for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan™ device, see the MRI SureScan™ technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results use Adobe Acrobat Reader® with the browser.
The data and content included in these presentations express only the clinical perspective of the presenter. They are completely independent and do not necessarily reflect the opinions of Medtronic.
Heart Failure Society of America (HFSA) 22nd Annual Scientific Meeting. What Do Heart Failure Patients Really Want, and Do Doctors Get it? - Medscape Medical News - Nov 06, 2018. Available on-line at https://www.medscape.com/viewarticle/904440
Zabel M, Willems R, Lubinski A, et al. Clinical effectiveness of primary prevention implantable cardioverter-defibrillators: Results of the EU-CERT-ICD controlled multicenter cohort study. Eur Heart J. 2020 May 6. doi:10.1093/eurheartj/ehaa226
White-Williams C, Fazeli PL, Kirklin JK, Pamboukian SV, Grady KL. Differences in health-related quality of life by implant strategy: Analyses from the Interagency Registry for Mechanical-ly Assisted Circulatory Support. J Heart Lung Transplant. 2020;39(1):62-73. doi:10.1016/j.healun.2019.10.002
Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol. 2008;52(23):1834-1843